NVR
NVR NYSE Homebuilding Financials FY2016βFY2025
NVR's revenue fell 1.9% to $10.3 billion in fiscal 2025. Its net margin was 13.0%, down from 16.0% a year earlier. Free cash flow was $1.1 billion, down 18.5%. It paid out $1.8 billion in dividends and buybacks, 167% of free cash flow. The diluted share count fell 7.5%.
About these figures. NVR tags its senior notes with its own label, which the SEC's structured data leaves out, so debt and debt-based ratios are left blank.
What NVR does
No business description yet.
- Legal name
- NVR, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000906163-26-000018
0000906163
Revenue and margins
NVR had $10.3B of revenue in fiscal 2025, down 1.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 17.3% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.1B in fiscal 2025, 10.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
NVR returned $1.8B to shareholders in fiscal 2025, 167% of free cash flow. The diluted share count fell 7.5%.
Value NVR yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β and divides by 3.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 15.5x Β· peers 12.3x Β· sector 17.9x.
Balance sheet
Cash, debt and the ratios that show how comfortably NVR can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.6B | $2.6B | $3.2B | $2.7B | $2.0B |
| Interest coverage | 30.9x | 58.0x | 70.5x | 77.1x | 60.0x |
| Total assets | $5.8B | $5.7B | $6.6B | $6.4B | $5.9B |
| Total liabilities | $2.8B | $2.2B | $2.2B | $2.2B | $2.0B |
| Shareholders' equity | $3.0B | $3.5B | $4.4B | $4.2B | $3.9B |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.6M
2 insiders
Sold, 12 months
$9.0M
2 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | George OliverDirector | Bought | 63 | $6,431.51 | $0.4M | Form 4 |
| Apr 24, 2026 | Michael J DeVitoDirector | Bought | 11 | $6,699.50 | $0.1M | Form 4 |
| Feb 13, 2026 | Susan Williamson RossDirector | Sold | 200 | $7,922.06 | $1.6M | Form 4 |
| Feb 10, 2026 | Matthew B. KelpyVP, Chief Accounting Officer | Sold | 500 | $8,100.00 | $4.1M | Form 4 |
| Feb 5, 2026 | Susan Williamson RossDirector | Sold | 200 | $8,091.62 | $1.6M | Form 4 |
| Feb 4, 2026 | Susan Williamson RossDirector | Sold | 220 | $8,000.00 | $1.8M | Form 4 |
| Nov 3, 2025 | Michael J DeVitoDirector | Bought | 14 | $7,068.05 | $0.1M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | 1.5% | 4.7% | 3.6% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| NVR NVR | $16.8B | β1.9% | β | 10.6% | β | 15.5x | β | |
| Toll Brothers TOL | $13.2B | 1.1% | 15.7% | 9.4% | 13.6% | 11.2x | β | Compare β |
| KB Home KBH | $2.9B | β10.0% | β | 4.6% | β | 13.3x | β | Compare β |
| PulteGroup PHM | $22.8B | β3.5% | β | 10.1% | 17.9% | 12.9x | β | Compare β |
| M/I Homes MHO | $3.2B | β1.9% | 11.5% | 2.9% | β | 11.8x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.8B | $6.3B | $7.2B | $7.4B | $7.5B | $9.0B | $10.5B | $9.5B | $10.5B | $10.3B |
| Interest expense | $21.7M | $24.2M | $25.1M | $25.4M | $40.9M | $53.1M | $39.5M | $27.7M | $27.8M | $29.9M |
| Pretax income | $662M | $847M | $960M | $1.0B | $1.1B | $1.6B | $2.3B | $1.9B | $2.1B | $1.8B |
| Income tax | $236M | $309M | $163M | $147M | $177M | $354M | $528M | $337M | $434M | $422M |
| Net income | $425M | $538M | $797M | $879M | $901M | $1.2B | $1.7B | $1.6B | $1.7B | $1.3B |
| Diluted EPS | $103.61 | $126.77 | $194.80 | $221.13 | $230.11 | $320.48 | $491.82 | $463.31 | $506.69 | $436.55 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | $393M | $570M | $723M | $867M | $925M | $1.2B | $1.9B | $1.5B | $1.4B | $1.1B |
| Capital expenditure | $22.4M | $20.3M | $19.7M | $22.7M | $16.1M | $17.9M | $18.4M | $24.9M | $29.2M | $24.5M |
| Free cash flow | $371M | $550M | $703M | $844M | $909M | $1.2B | $1.9B | $1.5B | $1.3B | $1.1B |
| Depreciation and amortization | $22.3M | $22.7M | $20.2M | $20.8M | $22.0M | $19.5M | $17.4M | $16.9M | $18.4M | $24.5M |
| Stock-based compensation | $43.6M | $44.6M | $75.7M | $78.5M | $50.8M | $58.2M | $82.5M | $99.5M | $73.9M | $69.2M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $455M | $422M | $846M | $698M | $371M | $1.5B | $1.5B | $1.1B | $2.1B | $1.8B |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $455M | $422M | $846M | $698M | $371M | $1.5B | $1.5B | $1.1B | $2.1B | $1.8B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $416M | $690M | $732M | $1.2B | $2.8B | $2.6B | $2.6B | $3.2B | $2.7B | $2.0B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $7.1M | $16.2M | $15.4M | $15.0M | $15.0M | $40.0M | $42.5M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Total assets | $2.6B | $3.0B | $3.2B | $3.8B | $5.8B | $5.8B | $5.7B | $6.6B | $6.4B | $5.9B |
| Total liabilities | $1.3B | $1.4B | $1.4B | $1.5B | $2.7B | $2.8B | $2.2B | $2.2B | $2.2B | $2.0B |
| Shareholders' equity | $1.3B | $1.6B | $1.8B | $2.3B | $3.1B | $3.0B | $3.5B | $4.4B | $4.2B | $3.9B |
| Margins | ||||||||||
| EBITDA margin | 12.1% | 14.2% | 14.0% | 14.5% | 15.1% | 18.6% | 22.0% | 20.7% | 20.5% | 17.6% |
| Net margin | 7.3% | 8.5% | 11.1% | 11.9% | 12.0% | 13.8% | 16.4% | 16.7% | 16.0% | 13.0% |
| FCF margin | 6.4% | 8.7% | 9.8% | 11.4% | 12.1% | 13.7% | 17.6% | 15.5% | 12.8% | 10.6% |
| Returns | ||||||||||
| Return on equity | 33.4% | 36.9% | 46.7% | 42.3% | 33.1% | 40.5% | 53.0% | 40.4% | 39.2% | 33.2% |
| Return on assets | 16.5% | 19.1% | 25.9% | 25.2% | 18.8% | 21.3% | 30.0% | 26.0% | 25.9% | 21.9% |
| Growth | ||||||||||
| Revenue growth | 12.9% | 8.3% | 13.6% | 3.1% | 2.0% | 18.8% | 17.6% | β9.6% | 10.6% | β1.9% |
| Net income growth | 11.1% | 26.4% | 48.3% | 10.2% | 2.6% | 37.2% | 39.5% | β7.8% | 5.7% | β20.3% |
| EPS growth | 15.1% | 22.4% | 53.7% | 13.5% | 4.1% | 39.3% | 53.5% | β5.8% | 9.4% | β13.8% |
| FCF growth | 77.8% | 48.4% | 27.9% | 20.0% | 7.7% | 34.7% | 51.2% | β20.4% | β8.7% | β18.5% |
| Share count change | β3.6% | 3.3% | β3.5% | β2.9% | β1.4% | β1.5% | β9.1% | β2.1% | β3.4% | β7.5% |
| Financial health | ||||||||||
| Interest coverage | 31.5x | 36.0x | 39.3x | 41.4x | 27.4x | 30.9x | 58.0x | 70.5x | 77.1x | 60.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.4% | 0.3% | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% | 0.2% |
| Stock comp / revenue | 0.8% | 0.7% | 1.1% | 1.1% | 0.7% | 0.7% | 0.8% | 1.1% | 0.7% | 0.7% |
| Payouts / FCF | 122.9% | 76.8% | 120.3% | 82.8% | 40.8% | 125.6% | 81.0% | 73.4% | 153.0% | 167.2% |
| Quality scores | ||||||||||
| Accruals ratio | 1.3% | β1.2% | 2.4% | 0.3% | β0.5% | β0.1% | β2.5% | 1.5% | 4.7% | 3.6% |
Source: SEC EDGAR XBRL filings (CIK 0000906163). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.